Is GlobalFoundries On The Verge Of A Breakout?
GLOBALFOUNDRIES Inc. (NASDAQ:GFS) is as a semiconductor foundry whose chips…
Sell
40
KPTI Quote, Financials, Valuation and Earnings
Last price:
$4.73
Seasonality move
:
-5.11%
Day range:
$5.02 - $5.30
52-week range:
$3.51 - $17.85
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.32x
P/B ratio:
--
Volume:
41.5K
Avg. volume:
89.1K
1-year change:
-69.85%
Market cap:
$44.5M
Revenue:
$145.2M
EPS (TTM):
-$13.27
Karyopharm Therapeutics Number of Insider Trades
Karyopharm Therapeutics Volume of Insider Trades
Number of Insiders Buying
22
(Last 3 Months)
Number of Insiders Buying
22
(Last 6 Months)
Current Insider Ownership Percentage
35.9%
Number of Insiders Selling
11
(Last 3 Months)
Number of Insiders Selling
14
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Karyopharm Therapeutics Insider Trading
-
How Much of KPTI Stock is Owned By Insiders?
35.9% of Karyopharm Therapeutics stock is owned by insiders.
-
Have Insiders Have Been Buying or Selling KPTI Stock?
Yes, insiders have been buying 978.3K shares of KPTI stock for a value of $8.4M. Insiders have also been selling 40.4K shares of KPTI for a total of $294.8K over the last 3 months.
-
How Much KPTI Stock was Sold by Insiders Last Quarter?
Over the last quarter, 40.4K shares of KPTI were sold by insiders for a total value of $294.8K.
-
How Much KPTI Stock was Bought by Insiders Last Quarter?
KPTI insiders bought $8.4M worth of stock representing 978.3K shares.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Dick’s Sporting Goods Buying Foot Locker Smart?
Last week, Dick’s Sporting Goods (NYSE:DKS) announced that it would…
Is Ginkgo Bioworks Stock a Good Buy?
Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
71
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Alerts
Buy
55
RGC alert for May 21
Regencell Bioscience Holdings [RGC] is down 3.24% over the past day.
Buy
64
AKRO alert for May 21
Akero Therapeutics [AKRO] is up 1.56% over the past day.
Buy
76
AGYS alert for May 21
Agilysys [AGYS] is down 1.32% over the past day.
